Mirum Pharmaceuticals (MIRM) Competitor Comparison
We are evaluating the key criteria listed to compare Mirum Pharmaceuticals (MIRM) against its competitors in the Biotechnology industry.
Market Capitalization
105 / 368Gross Profits
57 / 278Total Revenue
77 / 300EBITDA
207 / 337Free Cashflow
270 / 352Quick Ratio
192 / 357Earnings per Share
231 / 359Dividend yield
0 / 6Total Cash
111 / 358Performance 3 years
27 / 368Performance 5 years
67 / 368Performance 10 years
34 / 368Linearity 3 years
332 / 368Linearity 5 years
235 / 368Linearity 10 years
341 / 367Total Rank
202 / 368Dividend Rank
208 / 368Valuation Rank
72 / 368Piotroski Rank
243 / 368Muliplier Rank
159 / 368Market Capitalization - MIRM ranking 105 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.